Equilliumincis A Clinical Stage Biotechnology Company Based In La Jollacaliforniathe Company Specializes In Immunobiologyfocusing On Developing Novel Therapeutics For Severe Autoimmune And Inflammatory Disorders That Have High Unmet Medical Needsequillium Aims To Make A Significant Impact On Patientslives By Pioneering Innovative Therapies The Company S Product Pipeline Includes Several Immunomodulatory Assets Targeting Immuno Inflammatory Pathwaysnotable Products In Development Are Eq001Itolizumab A First In Class Monoclonal Antibody That Inhibits Pathogenic Pathways For Effector T Cell Developmenteq101Aimed At Treating Cutaneous T Cell Lymphoma And Alopecia Areataand Eq102Which Targets Various Gastrointestinal Diseasesequillium Collaborates With Partners Like Biocon To Advance Its Research And Commercialization Efforts
